Actively Recruiting
Evaluating Weekly Petrelintide Injections Versus Placebo for Adults With Overweight or Obesity A Phase III Randomized Controlled Study on Weight Management
Led by Hoffmann-La Roche · Updated on 2026-10-07
3900
Participants Needed
3
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects and safety of petrelintide compared with a placebo in adults who are overweight or have obesity, with at least one related health condition but without Type 2 Diabetes. This Phase III trial aims to assess how petrelintide, combined with a reduced-calorie diet and increased physical activity, supports weight management over time. Participants will receive either petrelintide or a matching placebo through weekly subcutaneous injections using a drug-device combination. The study lasts 64 weeks, during which all participants will follow a calorie-restricted diet and increase physical activity. The trial uses a randomized, double-blind design to compare the outcomes between the two groups. Throughout the study, participants will be regularly assessed for changes in body weight, waist circumference, blood markers like cholesterol and glucose, blood pressure, quality of life, and physical functioning. Safety will be monitored by tracking adverse events and immune responses. The main focus is the percentage change in body weight from the start to week 64. Participants involvement includes periodic visits for evaluations, questionnaires, and health measurements to monitor progress and safety.
CONDITIONS
Brief Title
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Research Team
R
Reference Study ID Number: CC46368 https://forpatients.roche.com/No attachments to email below.
F
Fastest Response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here